“尼美舒利”风波再次警示,我国在药物上市再评价、药物警戒观念、儿科用药立法等方面都有待加强和完善。最近一段时间,媒体上频频爆出有关退烧药“尼美舒利致命”的新闻。在国家药监局未做出回应之前,各地药店已经自发地将“尼美舒利”下架。随后,某国内尼美舒利生产商指出,该传闻系国外制药商为竞争退烧药市场恶意所为,并向当地法院提起诉讼。 “Nimesulide ” storm once again warned that our country in the drug re-evaluation of the market, the concept of warning drugs, pediatric medicine legislation and other areas need to be strengthened and improved. Recently, the media broke the news about antipyretics “fatally” Nimesulide. Before the State Food and Drug Administration did not respond, pharmacies in all parts of the country have voluntarily shelled the Nimesulide. Subsequently, a domestic Nimesulide producer pointed out that the rumor was that foreign drug makers were malicious about the anti-fever drug market and filed a lawsuit in local courts.